Gene · 5890
Papers1,861
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,861
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular residual disease detection in resected, muscle-invasive urothelial cancer with a tissue-based comprehensive genomic profiling-informed personalized monitoring assay. | Front Oncol | 2023 | 37601688 | PubTator, text mining | PubMed |
| Inhibitory mechanism of CRISPR-Cas9 by AcrIIC4. | Nucleic Acids Res | 2023 | 37587688 | PubTator, text mining | PubMed |
| Long-molecule scars of backup DNA repair in BRCA1- and BRCA2-deficient cancers. | Nature | 2023 | 37587346 | PubTator, text mining | PubMed |
| Golden ratio and self-similarity in swimming: breast-stroke and the back-stroke. | Front Hum Neurosci | 2023 | 37554410 | PubTator, text mining | PubMed |
| BRCA-deficient metastatic prostate cancer has an adverse prognosis and distinct genomic phenotype. | EBioMedicine | 2023 | 37549632 | PubTator, text mining | PubMed |
| The largest HIV-1-infected T cell clones in children on long-term combination antiretroviral therapy contain solo LTRs. | mBio | 2023 | 37530525 | PubTator, text mining | PubMed |
| DNA Damage Repair Pathways in Prostate Cancer: A Narrative Review of Molecular Mechanisms, Emerging Biomarkers and Therapeutic Targets in Precision Oncology. | Int J Mol Sci | 2023 | 37511177 | PubTator, text mining | PubMed |
| The Roles of Exosomes in Ovarian Cancer Chemo-resistance. | J Cancer | 2023 | 37497408 | PubTator, text mining | PubMed |
| RAD51C-XRCC3 structure and cancer patient mutations define DNA replication roles. | Nat Commun | 2023 | 37488098 | PubTator, text mining | PubMed |
| Salivary glands adenoid cystic carcinoma: a molecular profile update and potential implications. | Front Oncol | 2023 | 37476370 | PubTator, text mining | PubMed |
| The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma. | Nat Commun | 2023 | 37474499 | PubTator, text mining | PubMed |
| CRISPR/Cas9 as a therapeutic tool for triple negative breast cancer: from bench to clinics. | Front Mol Biosci | 2023 | 37469704 | PubTator, text mining | PubMed |
| Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges. | Mil Med Res | 2023 | 37460924 | PubTator, text mining | PubMed |
| "DEPHENCE" system-a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer-a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies. | Front Oncol | 2023 | 37448521 | PubTator, text mining | PubMed |
| Selective Killing of BRCA2-Deficient Ovarian Cancer Cells via MRE11 Blockade. | Int J Mol Sci | 2023 | 37446144 | PubTator, text mining | PubMed |
| Synaptonemal Complex in Human Biology and Disease. | Cells | 2023 | 37443752 | PubTator, text mining | PubMed |
| Impact of DNA damage repair alterations on prostate cancer progression and metastasis. | Front Oncol | 2023 | 37434977 | PubTator, text mining | PubMed |
| A new compact adenine base editor generated through deletion of HNH and REC2 domain of SpCas9. | BMC Biol | 2023 | 37434184 | PubTator, text mining | PubMed |
| Update on poly(ADP-ribose) polymerase inhibitors resistance in ovarian cancer. | Front Pharmacol | 2023 | 37426808 | PubTator, text mining | PubMed |
| Homologous recombination pathway gene variants identified by tumor-only sequencing assays in lung carcinoma patients. | Transl Lung Cancer Res | 2023 | 37425424 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5890/papers?page=10